(Adds share movement in paragraph 2) By Michael Erman Feb 28 (Reuters) – COVID-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and pick up market share from much larger rivals, Pfizer and Moderna The company posted a larger-than-expected […]